Z-0506-2016 Class III Terminated
FDA device recall Z-0506-2016 was initiated by Ameditech Inc on Nov 16, 2015 and is designated Class III. Reason for recall: Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the… The recall status is terminated (terminated Nov 9, 2016). Affected quantity: 8,290 units.
Recall details
- Product Type
- Devices
- Report Date
- Dec 30, 2015
- Initiation Date
- Nov 16, 2015
- Termination Date
- Nov 9, 2016
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 8,290 units
Product description
iCup DX 8 Panel w/Adulterant, Item No. I-DXA-187-016
Reason for recall
Ameditechs Drugs of Abuse Tests listed above have shown reduced reactivity for up to two (2) of the nineteen (19) Benzodiazepine (BZO) compounds for which specificity information is provided in the product insert. The particular BZO compounds for which there may be reduced reactivity are Clonazepam and Chlordiazepoxide.
Distribution pattern
Nationwide Distribution.
Code information
141971 142195 142397 142674 142997 144209 144463 150018 150883 151525 151526 152180 152741 153045 153150 153151 153211 153376 153650
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0506-2016
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026